This study tests an experimental drug called berubicin in adults whose glioblastoma (a fast-growing brain tumor) has come back after standard treatment. About 252 participants will receive either berubicin or the standard chemotherapy lomustine. The main goal is to see if berubic…
Phase: PHASE2 • Sponsor: CNS Pharmaceuticals, Inc. • Aim: Disease control
Last updated Apr 29, 2026 02:24 UTC